Renard E - Search Results

1

Closed-loop driven by control-to-range algorithm outperforms threshold-low-glucose-suspend insulin delivery on glucose control albeit not on nocturnal hypoglycaemia in prepubertal patients with type 1 diabetes in a supervised hotel setting.

Renard E, Tubiana-Rufi N, Bonnemaison-Gilbert E, Coutant R, Dalla-Vale F, Farret A, Poidvin A, Bouhours-Nouet N, Abettan C, Storey-London C, Donzeau A, Place J, Breton MD. Renard E, et al. Diabetes Obes Metab. 2019 Jan;21(1):183-187. doi: 10.1111/dom.13482. Epub 2018 Aug 21. Diabetes Obes Metab. 2019. PMID: 30047223 Clinical Trial.

2

Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials.

Renard E, Baldet P, Picot MC, Jacques-Apostol D, Lauton D, Costalat G, Bringer J, Jaffiol C. Renard E, et al. Diabetes Care. 1995 Mar;18(3):300-6. doi: 10.2337/diacare.18.3.300. Diabetes Care. 1995. PMID: 7555471

3

Cecum erosion: unusual but serious complication of an implanted catheter for peritoneal insulin delivery.

Renard E, Taourel P, Quenet F, Domergue J, Bruel JM, Bringer J. Renard E, et al. Diabetes Care. 1995 Mar;18(3):408-9. doi: 10.2337/diacare.18.3.408. Diabetes Care. 1995. PMID: 7555488 No abstract available.

4

Complications of the pump pocket may represent a significant cause of incidents with implanted systems for intraperitoneal insulin delivery.

Renard E, Bringer J, Jacques-Apostol D, Lauton D, Mestre C, Costalat G, Jaffiol C. Renard E, et al. Diabetes Care. 1994 Sep;17(9):1064-6. doi: 10.2337/diacare.17.9.1064. Diabetes Care. 1994. PMID: 7988309

5

[How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?].

Guerci B, Jeandidier N, Lassmann-Vague V, Renard E, Hanaire-Broutin H. Guerci B, et al. Among authors: renard e. Diabetes Metab. 2000 Dec;26(6):513-9. Diabetes Metab. 2000. PMID: 11173725 Review. French.

6

[Insulin therapy in type 1 diabetes for and during pregnancy: by which means and for which objectives?].

Renard E, Raingeard I, Boulot P, Bringer J. Renard E, et al. Diabetes Metab. 2001 Sep;27(4 Pt 2):S61-6. Diabetes Metab. 2001. PMID: 11787439 Review. French.

7

Comparison of blood glucose stability and HbA1C between implantable insulin pumps using U400 HOE 21PH insulin and external pumps using lispro in type 1 diabetic patients: a pilot study.

Catargi B, Meyer L, Melki V, Renard E, Jeandidier N; EVADIAC Study Group. Catargi B, et al. Among authors: renard e. Diabetes Metab. 2002 Apr;28(2):133-7. Diabetes Metab. 2002. PMID: 11976565

8

[From external to implantable insulin pump, can we close the loop?].

Renard E, Costalat G, Bringer J. Renard E, et al. Diabetes Metab. 2002 Sep;28(4 Pt 2):2S19-2S25. Diabetes Metab. 2002. PMID: 12442060 French.

9

Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.

Renard E. Renard E. Curr Opin Pharmacol. 2002 Dec;2(6):708-16. doi: 10.1016/s1471-4892(02)00216-3. Curr Opin Pharmacol. 2002. PMID: 12482735 Review.

10

[Insulin therapy by insulin pump: continuous or conventional self-blood glucose monitoring? ].

Renard E. Renard E. Diabetes Metab. 2003 Apr;29(2 Pt 2):S54-62. Diabetes Metab. 2003. PMID: 12746628 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

481 results

Search Page

Filters